Synpromics Ltd, a synthetic promoter and gene control company, has entered a collaboration with Sartorius Stedim Cellca to evaluate and test its customized synthetic promoters with Sartorius’ mammalian production cell platform. The program aims to reduce timelines and increase yields in the development of stable cell lines for the production of biopharmaceuticals.   Cellca has developed the Cellca CHO Expression Platform, an efficient system for the production of biologicals using CHO (Chinese...